First Trust Advisors’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
First Trust Advisors's IMVT Position: Q3 2026 in Review
First Trust Advisors increased its Immunovant (IMVT) stake by 23% in Q3 2026, buying an estimated $48.1K and bringing the position to 6,625 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #2599.
First Trust Advisors first reported a position in IMVT in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.6M in Q4 2023. 232 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.
- First Trust Advisors held 6,625 shares of Immunovant worth $224K as of Q3 2026.
- First Trust Advisors bought 1,220 Immunovant shares in Q3 2026, an estimated $48.1K.
- Immunovant made up ﹤0.01% of First Trust Advisors's portfolio in Q3 2026, its #2599 holding.
- First Trust Advisors first reported a position in Immunovant in Q4 2023 and has held it in 4 quarters since.
- First Trust Advisors's Immunovant position peaked at $1.6M in Q4 2023.
- 232 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.
Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.